Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-409-2 | CAS number: 1329-99-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 27, 2012- July 5, 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to GLP and valid methods, therefore it is considered relevant, reliable and adequate for classification.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Reaction mass of 1-Methyl-4-(1-methylethenyl)cyclohexene and 1-Methyl-4-(1-methylethylidene)-cyclohexene and 1-methyl-4-(propan-2-yl)cyclohexa-1,3-diene
- EC Number:
- 939-409-2
- Cas Number:
- 1329-99-3
- Molecular formula:
- C10H16
- IUPAC Name:
- Reaction mass of 1-Methyl-4-(1-methylethenyl)cyclohexene and 1-Methyl-4-(1-methylethylidene)-cyclohexene and 1-methyl-4-(propan-2-yl)cyclohexa-1,3-diene
- Reference substance name:
- Isopropylmethylcyclohexane, tetradehydro derivative
- EC Number:
- 215-532-0
- EC Name:
- Isopropylmethylcyclohexane, tetradehydro derivative
- Cas Number:
- 1329-99-3
- IUPAC Name:
- 1-isopropyl-4-methylcyclohexane
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): Depanol I
- Substance type: Organic multi constituent
- Physical state: Liquid, colourless, characteristic odour
- Analytical purity: Terpene hydrocarbons: 98.9% (w/w); p- Menthadienes: 96.3% (w/w)
- Composition of test material, percentage of components & impurities: See confidential details
- Purity test date: 2011-07-06
- Lot/batch No.: DEFM102174
- Expiration date of the lot/batch: 25-06-2013
- Stability under test conditions: Not provided
- Storage condition of test material: At room temperature in the original, tightly closed container, in a well-ventilated place
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: TOXI-COOP ZRT., H-1103, Budapest, Crezrkesz u. 90
- Age at study initiation: Young adult mice, 12 week old
- Weight at study initiation: 17.5-22.6 g ; the weight variation in animals involved in the study did not exceed ±20% of the mean weight
- Fasting period before study: no data
- Housing: 4 animals/cage, Type II Polypropylene/polycarbonate cages; deep wood sawdust bedding: Lignocel® Hygienic Animal Bedding ( J. Rettenmaier & Söhne GmbH +CO KG ,D-73494 Rosenberg (Germany) Holzmühle 1)
- Diet (e.g. ad libitum): sniff® SM R/M-Z+H complete diet for rats and mice produced by ssniff Spezialdiäten GmbH, D-59494 Soest, Germany, ad libitum
- Water (e.g. ad libitum): Tap water from municipal supply as for human consumption, from a bottle, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±3°C
- Humidity (%): 30-70%
- Air changes (per hr): Not provided
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: June 20 to July 02, 2012.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Remarks:
- (AOO)
- Concentration:
- 50%, 25%, 10% and 5% (w/v)
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: The test item was a liquid,hence applicability of the 100 % concentration (the undiluted test item) was evaluated. Further test concentrations were achieved by formulation of the test item in Acetone: Olive oil 4:1 (v/v) mixture (AOO). Both the undiluted test item and the formulations were adequately applicable on the ears of animals. Concentration series of 100 %, 75 %, 50 %, 25 % and 10 % were tested in two preliminary irritation/toxicity tests.
- Irritation: Significant toxic and irritation effects were observed at 100 % and 75 % concentrations. The effects (toxicity an irritation) observed at 50 % were ambiguous. In order to test the highest concentration possible 50 % was selected as the maximum concentration used in the main test together with three additional, lower concentrations (25 %, 10 % and 5 %).
-Lymph node proliferation response: Visual appearance of the lymph nodes.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: Stimulation Index (SI) versus control.
- Other criteria examined: body weigth, clinical observations, including ear thickness, erythema and edema.
The test item is considered as a skin sensitizer, if the following criteria are fulfilled:
-Exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than recorded in control mice, as indicated by the stimulation index.
- Data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The stimulation index values were 22.6, 16.1, 7.1 and 1.8 at test item concentrations of 50 %, 25 %, 10 % and 5 %, respectively. Significance of the dose-response was evaluated by linear regression using SI values. Statistically significant dose-response was observed (p = 0.035; r value = 0.965). EC3 calculation was conducted by linear interpolation using data points lying immediately above and below the SI value of 3 on the LLNA dose-response curve based on published method. The calculated EC3 value of Depanol I was 6.1 % in this LLNA.
Results and discussion
- Positive control results:
- The positive control group animals were treated with 25 % (w/v) HCA solution (dissolved in AOO) concurrent to the test item groups. No mortality, cutaneous reactions or signs of toxicity were observed in the positive control group.
Significant lymphoproliferative response (SI >3) was noted for HCA (SI = 3.6). The results of the positive control item demonstrated appropriate performance of the test in accordance with the relevant guidelines and confirmed validity of the assay.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: Reading: other: Stimulation index (SI) = 1.8. Group: test group. Dose level: 5%. No with. + reactions: 0.0. Total no. in groups: 4.0.
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: Reading: other: Stimulation index (SI) = 7.1. Group: test group. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 4.0.
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: Reading: other: Stimulation index (SI) = 16.1. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 4.0.
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: Reading: other: Stimulation index (SI) = 22.6. Group: test group. Dose level: 50%. No with. + reactions: 4.0. Total no. in groups: 4.0. Clinical observations: increased ear thickness.
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: Reading: other: Stimulation index (SI) = 3.6. Group: positive control. Dose level: 25% HCA. No with. + reactions: 3.0. Total no. in groups: 4.0. Clinical observations: increased ear thickness.
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: Reading: other: Stimulation index (SI) = 1.0. Group: negative control. Dose level: AOO. Total no. in groups: 4.0.
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- The stimulation index (SI = the DPN of a treated (positive control or test item) group divided by the DPN of the respective negative control group) for each treatment group was also calculated. A stimulation index of 3 or greater is an indication of a positive result. Based on the results EC3 value = 6.1% (dose calculated to induce a stimulation index of 3) of the test item was calculated. Larger than the control lymph nodes was observed in the positive control group, in the 50 % and the 25 % dose group. Appearance of the lymph nodes was normal in the negative (vehicle) control group and in the 10 % or 5 % test item treated groups. In spite of normal visual appearance of the lymph nodes in the 10 % dose group significant (SI > 3) lymphoproliferative response was noted for Depanol I at concentrations of 50 %, 25 % and 10 %. The observed stimulation index values were 22.6, 16.1, 7.1 and 1.8 at test item concentrations of 50 %, 25 %, 10 % and 5 %, respectively. Significance of the dose-response was evaluated by linear regression using SI values. Statistically significant dose-response was observed (p = 0.035; r value = 0.965).
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- DPM (disintegration per minute) was measured for each treatment group in both Experiments. The measured DPM values were corrected with the background DPM value. The average of the two measured DPM values of 5 % (w/v) trichloracetic acid solutions was used as the background DPM value. The results were expressed as DPN (DPM divided by the number of pooled lymph nodes).
Any other information on results incl. tables
The symptoms (both local and systemic) observed in the 50% dose group were not significant hence it was considered that the proliferation values observed could not have been significantly affected by an adverse effect of the test item. Since no signs of irritation or systemic toxicity were observed in the other test item treated groups (25%, 10% and 5%) the proliferation values obtained, are considered to reflect the real potential of the test item to cause lymphoproliferation in the Local Lymph Node Assay.
No significant, treatment related effect on body weights was observed during the test. No mortality was observed during the test. Decreased activity was observed in the 50% dose group (4/4 animals) on Day 3 (after the third treatment), but the effect was slight and all animals were normal on the subsequent days (Day 4 to Day 6).
Increased ear thickness values compared to the vehicle control were observed in the 50% dose group on Day 3 (3/4 animals, range 9.1 % - 19.0%) and Day 6 (4/4 animals, range 13.6 % - 40.9 %). The increase was significant in case of one ear of one animal on Day 6 (animal No.: 768, 40.9 % increase), but the other measured values were not significant (did not exceed 25 %). No significant erythema (score ≥ 3) was observed during the study in any treatment group.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information moderate Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the present Local Lymph Node Assay Depanol I, tested at concentrations of 50 %, 25 %, 10 % and 5 % as homogenous formulations (solutions) in a suitable vehicle (AOO) was shown to have sensitization potential (sensitizer). Based on the EC3 value = 6.1% of calculated using dose-response analysis, Depanol I was considered a moderate sensitizer in this LLNA.
- Executive summary:
Skin sensitization potential of Depanol I was tested in the Local Lymph Node Assay. The test item was a liquid, hence applicability of the 100 % concentration as well as formulations in Acetone: Olive oil 4:1 (v/v) mixture (AOO) at 75 %, 50 %, 25 % and 10 % were tested in two preliminary irritation/toxicity tests. Significant toxic and irritation effects were observed at 100 % and 75 % concentrations, whereas the effects (toxicity an irritation) observed at 50 % were ambiguous. 50 % was selected as the maximum concentration used in the main test together with three additional, lower concentrations (25 %, 10 % and 5 %).
In the main test 24 female CBA/Ca mice were allocated to 6 groups of four animals each, including 4 different concentrations of 50%, 25%, 10% and 5%, the negative control group (AOO), and positive control group (α-Hexylcinnamaldehyde HCA). Each substance was applied on the external surface of each ear (25 µL/ear) of the animals for three consecutive days (Day1, 2 and 3). There was no treatment on Days 4, 5 and 6. On Day 6 animals were intravenously injected via the tail vein with tritiated methyl thymidene (3HTdR), then sacrificed approximately 5 hours after the injection. Auricural lymph nodes were removed and processed. The cell proliferation in the local lymph nodes was measured by incorporation of 3HTdR and the obtained values were used to calculate stimulation indices (SI).
The positive control item ( 25% HCA in AOO) induced the appropriate stimulation over the control (SI = 3.6), thus confirming the validity of the assay.
No mortality was observed during the study. No significant effect on body weight was observed in any treatment group during the test. Decreased activity was observed in the 50% dose group (4/4 animals) on Day 3 (after the third treatment), but the effect was slight and all animal was normal on the subsequent days (Day 4 to 6). No significant erythema (score ≥3) was observed during the study in any treatment group. As a local effect increased ear thickness values (compared to the vehicle control) were observed in the 50% dose group on Day 3 (3/4 animals) and Day 6 (4/4 animals), but the increase did not exceed the 25% treshold (except in case of one ear of one animal on Day 6; animal No. 768, 40.9% increase) hence the effect was considered not significant.
Larger lymph nodes than the control was observed in the positive control group and in the 50% and 25% dose groups. Visual appearance of the lymph nodes was normal in the other groups (both vehicle and test item treated). The stimulation index values were 22.6, 16.1, 7.1 and 1.8 at test item concentrations of 50%, 25%, 10% and 5% respectively. Significance of the dose-response was evaluated by linear regression using SI values. Statistically significant dose-response was observed (p= 0.035; r valuea= 0.965).
The symptoms (both local and systemic) observed in the 50% dose group were not significant hence it was considered that the proliferation values observed could not been significantly affected by an adverse effect of the test item. Since no signs of irritation or systemic toxicity were observed in the other test item treated groups (25%, 10% and 5%) the proliferation values obtained are considered to reflect the real potential of the test item to cause lymphoproliferation in the Local Lymph Node Assay.
According to evaluation criteria of the relevant guidelines, proliferation values above 3 at 50%, 25% and 10% and the significant dose-response observed, was considered evidence that Depanol I has sensitization potential. EC3calculation was conducted by linear interpolation using data points lying immediately above and below the SI value of 3 on the LLNA dose-response curve based on published method. The calculated EC3value of Depanol I was 6.1% in this LLNA. Using this EC3value according to the published data for classification of contact allergens Depanol I can be ranked among moderate sensitizers ( 1 ≤EC3< 10) in this LLNA.
In conclusion, under the conditions of the present Local Lymph Node Assay Depanol I, tested at concentrations of 50%, 25%, 10% and 5% as homogenous formulations (solutions) in a suitable vehicle (AOO) was shown to have sensitization potential (senitizer). Based on the EC3values calculated using dose-response analysis, Depanol I was considered a moderate sensitizer in this LLNA.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.